Trials / Completed
CompletedNCT05518539
Evaluation of Quality of Vision and Visual Outcomes With Bilateral Implantation of the Clareon PanOptix Intraocular Lens
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (actual)
- Sponsor
- Newsom Eye & Laser Center · Academic / Other
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- —
Summary
To evaluate visual outcomes and quality of vision following bilateral implantation of the Clareon PanOptix intraocular lens (IOL) targeted for emmetropia.
Detailed description
This study is a single-arm unmasked clinical evaluation study of binocular distance-corrected near (40 cm) visual acuity after successful bilateral cataract surgery. Subjects will be assessed pre-operatively, operatively and at 1 day, 1 month and 3 months post-operatively. Clinical evaluations will include administration of a visual disturbance questionnaire (QUVID), and a satisfaction questionnaire (IOLSAT), as well as measurement of bilateral visual acuity and manifest refraction.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | The Clareon™ PanOptix™ Trifocal (toric and non-toric models) | Bilateral implantation with the Clareon PanOptix Trifocal (toric and non-toric models) |
Timeline
- Start date
- 2022-09-08
- Primary completion
- 2024-06-14
- Completion
- 2024-06-14
- First posted
- 2022-08-26
- Last updated
- 2025-07-18
- Results posted
- 2025-07-18
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05518539. Inclusion in this directory is not an endorsement.